Agilent’s Balanced Outlook: Hold Rating Amid Growth Prospects and Valuation Concerns

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Agilent yesterday and set a price target of $130.00.

Michael Ryskin has given his Hold rating due to a combination of factors that suggest a balanced outlook for Agilent. The company’s long-term growth and margin prospects appear durable, supported by effective execution, a well-balanced portfolio, and cost initiatives. However, the current valuation seems to already reflect these positive aspects, leading to a Neutral stance.
Despite some temporary headwinds such as EU tariffs and variable compensation affecting margins, management expects these to be mitigated in the near term. Additionally, Agilent’s growth is supported by several tailwinds, including replacement cycles and new capacity in CDMO, which are expected to drive organic growth in the coming years. The company’s strategic initiatives, such as the Ignite program, are also contributing to operating margin expansion, reinforcing the decision to maintain a Hold rating.

A’s price has also changed slightly for the past six months – from $120.510 to $121.890, which is a 1.15% increase.